Fresenius Medical Care AG & Co KGaA (FMEG.DE) Quote| Reuters.com
Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

77.74EUR
8:57am EDT
Change (% chg)

€-0.21 (-0.27%)
Prev Close
€77.95
Open
€77.74
Day's High
€78.05
Day's Low
€77.36
Volume
195,776
Avg. Vol
549,980
52-wk High
€83.17
52-wk Low
€63.10

FMEG.DE

Chart for FMEG.DE

About

Fresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa... (more)

Overall

Beta: 0.29
Market Cap(Mil.): €23,896.77
Shares Outstanding(Mil.): 306.57
Dividend: 0.80
Yield (%): 1.03

Financials

  FMEG.DE Industry Sector
P/E (TTM): 24.29 55.83 35.71
EPS (TTM): 3.21 -- --
ROI: 6.83 5.40 14.23
ROE: 11.25 8.54 15.43

UPDATE 1-Fresenius net profit up 24 percent on generic intravenous drugs

* FMC Q1 net income up 9 pct on higher U.S. reimbursement (Adds details on intravenous drugs unit Kabi, FMC anaemia drug)

May 03 2016

BRIEF-FMC says 120,000 patients on Mircera at end-Q1

* Says 120,000 patients on Mircera at end-Q1 Further company coverage:

May 03 2016

Fresenius net profit up 24 percent on generic infusion drugs

FRANKFURT, May 3 German healthcare group Fresenius SE saw adjusted net income rise 24 percent in the first quarter, bolstered by the launch of new generic infusion drugs and rivals' supply shortages.

May 03 2016

Germany's FMC pulls out of bidding for Irish clinic chain - paper

FRANKFURT, May 1 German healthcare group Fresenius Medical Care (FMC) has pulled out of the bidding for Irish clinic chain Mater Private, daily Frankfurter Allgemeine Zeitung reported, citing people familiar with the matter.

May 01 2016

BRIEF-CTS Eventim in JV for Scandinavian ticketing operator

* Says cts eventim ag & co. kgaa: egmont and cts eventim create joint scandinavian ticketing operator

Mar 16 2016

BRIEF-FMC says Citi's McWhinney, Sanofi's Witz to run for supervisory board

* Says Gerd Krick, chairman of the supervisory board , to run again for supervisory board

Mar 11 2016

FMC aims for 110,000 U.S. patients to be on Mircera in first-quarter

FRANKFURT Kidney dialysis provider Fresenius Medical Care (FMC) expects more than 70 percent of eligible U.S. patients to have switched to cheaper alternative anemia treatment Mircera by the end of March, the German group's chief executive said.

Feb 24 2016

FMC aims for 110,000 U.S. patients to be on Mircera in Q1

FRANKFURT, Feb 24 Kidney dialysis provider Fresenius Medical Care (FMC) expects more than 70 percent of eligible U.S. patients to have switched to cheaper alternative anaemia treatment Mircera by the end of March, the German group's chief executive said.

Feb 24 2016

UPDATE 1-Fresenius eyes 8-12 pct profit growth on hospitals, dialysis

* Fresenius up 1.2 pct pre-market, FMC down 1 pct (Adds background on dialysis unit FMC, Helios hospitals, Kabi infusion drugs)

Feb 24 2016

FMC takes $60 mln pretax burden on GranuFlo settlement

FRANKFURT, Feb 17 Dialysis specialist Fresenius Medical Care (FMC) settled out of court for $250 million with U.S. plaintiffs who had accused the German company of understating the side effects of a medical product, it said late on Wednesday.

Feb 17 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Finlabo SIM Spa
$10.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.